Between November 19-21 2024, Jason joined over 500 public & private healthcare companies, institutional and private equity investors, and VCs at the Jefferies Global Healthcare Conference. The gathering specifically brought together 3,000 leading executives to address near-and long-term investment opportunities as well as the current trends driving healthcare in the U.S. and internationally.
GenScript – which runs concurrently with Jefferies London Healthcare Conference – convenes top scientists and industry leaders from around the world. The conference brought together gene and cell therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies to focus on recent developments in research, technological breakthroughs, AI in biopharmaceutical, and regulatory trends.
On November 20 2024, Jason spoke on a panel at the GenScript Biotech Global Forum London that explored cell therapies and novel technologies.